SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network ($ZBCN) is trending amid strong community anticipation for its Super App launch and significant tokenomics updates, including final token unlocks by March 2026, shifting to a deflationary model with buybacks. Recent integrations, such as the USD1 payroll and card services with World Liberty Financial, coupled with ISO 20022 compliance and ongoing blockchain partnerships, are driving widespread bullish sentiment among investors who view ZBCN as an undervalued utility project in institutional payment infrastructure.

Venus Concept, Inc. is a global medical technology company, which engages in the business of developing, commercializing, and selling minimally invasive and non-invasive medical aesthetic and hair restoration technologies. It operates under the United States and International geographical segments. The company was founded on November 22, 2002 and is headquartered in Toronto, Canada.

Venus Concept Inc

Venus Concept ($VERO) is trending after Madryn Asset Management acquired a 91% stake, fueling intense speculation about a potential short squeeze and privatization. Bulls anticipate massive upside, citing the extremely low public float, while others caution about dilution risks and predict a sharp correction after its significant surge. The community is actively debating whether the dominant ownership will lead to unprecedented price appreciation or a swift return to lower valuations.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin (APP) is trending amidst significant volatility, with recent analyst upgrades to price targets as high as $835 being met by a sharp stock price decline, fueling community debate. Bulls emphasize strong fundamentals, AI-driven growth through its AXON platform, and expansion into e-commerce, viewing the pullback as a market manipulation before anticipated strong earnings. Conversely, bears point to valuation concerns and potential competition from new entrants in the advertising space, including OpenAI, suggesting further downside.

London-based Quant Network is set to revolutionise blockchain technology with the development of their blockchain operating system Overledger. The experienced team are determined to fulfil the original vision of the internet by creating an open trusted network for people, machines, and data to operate securely and safely.  Overledger -the first interoperable blockchain operating system that facilitates internet-scale development of decentralised, multi-chain applications. Overledger has the ability to unlock and distribute value and applications across current and future blockchains. It is an agnostic platform that connects the world's networks to blockchains and ensures you're not limited to any single a vendor or technology. Overledger is the only platform that facilitates the development of internet-scales development of decentralised, multi-chain applications.

Quant

Quant (QNT) is trending as its core Overledger technology is reportedly powering real-world enterprise adoption, notably in the UK's tokenized deposit pilot involving major banks. This development, alongside its low token supply and focus on bridging traditional finance with blockchain, fuels optimistic long-term price predictions among proponents, even as some express impatience with current price movements.

Wishing Well

WISH CRYPTO is trending amidst an active weekend event designed to reward holders and grow its community. Enthusiasts are highly bullish, citing its unique deflationary tokenomics that match US inflation rates and a robust community backing it as a long-term, utility-driven Solana memecoin, especially with CoinGecko listing and StockTwits chart activation expected to significantly boost its visibility.

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

Atlassian (TEAM) is trending due to a severe, unexplained sell-off that has driven the stock to multi-year lows, despite recent strong earnings beats, raised guidance, and a significant share buyback authorization. Community sentiment is sharply divided; many bulls see an unjustified capitulation and a major buying opportunity, while bears highlight ongoing insider selling and broader sector skepticism about AI's impact on software platforms.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio ($IBRX) is experiencing significant momentum driven by the Saudi FDA's accelerated approval of its ANKTIVA drug for non-small cell lung cancer and bladder cancer, alongside preliminary reports of substantial ANKTIVA revenue growth. The community is buzzing with optimism, anticipating further international partnerships and US regulatory advancements, viewing these developments as pivotal steps towards realizing the drug's broad potential in oncology. Many are discussing a potential short squeeze given the massive trading volume and positive news, reinforcing conviction in the company's long-term vision to redefine cancer treatment.

Venture Global, Inc. engages in the development and construction of liquefied natural gas production, establishing us as a rapidly growing company delivering critical LNG to the world. It projects include Calcasieu, Plaquemines, CP2, CP3 and Delta projects. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is trending as investors highlight strong operational execution, with increased LNG output from its Plaquemines facility and favorable margins driven by European demand and cold weather. The community is actively discussing the company's rapid expansion and high short interest, anticipating a potential short squeeze despite ongoing legal disputes. Many view the stock as significantly undervalued given its position to capitalize on robust global LNG demand.

Figma, Inc. is an AI-powered design platform that enables seamless collaboration across the entire product development lifecycle. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is experiencing significant volatility, with much of the community's concern centered on a prolonged sell-off amplified by ongoing insider selling and upcoming lock-up expirations. While many users express frustration over what they perceive as an "IPO pump and dump," others view the declining valuation as a strategic long-term entry point, emphasizing Figma's market position and AI integration potential in the evolving software landscape.

The Internet Computer is a decentralized cloud blockchain designed to run applications, websites, and backend systems fully on-chain. Its architecture provides robust security, resilience, and built-in multi-chain support.  A key focus of the network is enabling a “self-writing cloud,” where AI tools allow users generate applications through natural-language instructions.  Developers and users can experiment with the platform using AI app-generation tools like caffeine.ai or by writing serverless code directly through online IDEs such as icp.ninja.  The ICP token is used to pay for computation (through a burn-based model) and to participate in network governance through staking.

Internet Computer

The Internet Computer (ICP) is trending due to active discussions surrounding its "Mission 70" tokenomics, aimed at significantly reducing inflation and boosting network usage. The community is highlighting ICP's advanced technology, including Chain Fusion and AI integration, positioning it as an undervalued asset with real-world utility for decentralized cloud services. Many foresee a major move driven by fundamental adoption, despite ongoing debates about its past price volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) Short Interest Update

Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP - Get Free Report) was the recipient of a significant increase in short interest in December. As of December 31st, there was short interest totaling...

Coeptis Therapeutics (NASDAQ:COEP) Trading Up 2.7% - Still a Buy?

Coeptis Therapeutics (NASDAQ:COEP) Trading Up 2.7% - Time to Buy...

Coeptis Therapeutics (NASDAQ:COEP) Stock Price Down 3.6% - Time to Sell?

Coeptis Therapeutics (NASDAQ:COEP) Shares Down 3.6% - What's Next...

Coeptis Therapeutics (NASDAQ:COEP) Stock Price Up 12.2% - What's Next?

Coeptis Therapeutics (NASDAQ:COEP) Stock Price Up 12.2% - Time to Buy...

This account has been verified as an official COEP representative.

Verified Account

Coeptis Therapeutics

Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company, which engages in developing innovative cell therapy platforms for cancer that can disrupt conventional treatment paradigms and improve patient outcomes. It operates through the Biotechnology and Technology segments. The Biotechnology segment is involved in developing biotechnology product pipelines. The Technology segment relates to acquiring technology assets to support and enhance operational capabilities through advanced technologies. The company was founded in 2017 and is headquartered in Wexford, PA.

Coeptis Therapeutics Holdings Inc

Coeptis Therapeutics Inc

Rising short interest, doubling as of 12/31, fuels speculation of a potential short squeeze, creating "dangerous" territory for bearish positions.

Traders eagerly await the impending merger completion and the highly anticipated PR release, speculating on immediate price movement once the news drops.

Current Price	$12.90
Prev Close	$13.65
Open	$13.66
Dividend Yield	0.00%
50-Day Moving Average	$15.23
Beta	0.39
Avg. Volume	100,848.64
PE Ratio	-3.21

52-Week High	$21.41
52-Week Low	$6.26
Market Capitalization	$77.53M
EPS (Annual)	-$5.65
Price to Book	5.24
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

COEP
Coeptis Therapeutics Inc

Feed

News

Sentiment

Fundamentals

Info

Latest COEP News

COEPCoeptis Therapeutics Inc